Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen.
No abstract text is available yet for this article.
Full text links
We have located links that may give you full text access.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app